Cell Therapy
CDMO Services
Cell Therapies. Delivered.
Welcome to Minaris Cell Therapies
Minaris Cell Therapies brings together proven cell therapy manufacturing experience, robust quality systems and commercial execution. With more than 25 years of experience and over 7,500 GMP batches produced, we support autologous and allogeneic programs across development, clinical manufacturing and commercialization.
Our integrated process development, analytical, testing, technology transfer and GMP manufacturing capabilities are designed to deliver the control, consistency and quality required as programs advance toward market. From CAR-T and TCR-T to TIL, NK/CAR-NK, MSC, HSC and iPSC- based therapies, we provide the expertise and manufacturing foundation to support successful scale-up and commercial supply.
25+
Years of cell therapy experience
7,500+
Clinical and commercial GMP batches produced
4
Commercially experienced sites across 3 continents
30+
Inspections passed by global health authorities
Our Cell Therapy Capabilities
-
Cell Banking
Cell Banking
Minaris provides cGMP cell banking services that establish reliable, reproducible starting materials for advanced therapy development and manufacturing. With over 20 years of expertise, we generate research, master, and working cell banks designed to support long-term program consistency, traceability, and regulatory readiness.
-
Technology Transfer
Technology Transfer
Minaris applies a robust technology transfer framework to de-risk program onboarding. Whether your process is early-stage or commercial-ready, our cross-functional teams ensure fast, efficient and traceable handoff.
-
Cell Therapy Process Development
Cell Therapy Process Development
Our process development scientists help you translate R&D protocols into GMP-compliant, more closed, automated workflows, optimizing yield, viability, formulation, cryopreservation, process duration and consistency across both autologous and allogeneic cell therapy platforms. Our analytical development teams have created analytical test methods that are fit for their purpose, scientifically valid, and ready for release or support clinical processes as in-process controls (IPCs). These methods meet the requirements of health authorities by describing final products’ safety, identity, strength, quality and purity.
-
Cell Therapy GMP Manufacturing
Cell Therapy GMP Manufacturing
With GMP facilities in the US, Germany and Japan, Minaris provides clinical and commercial manufacturing for cell therapies. Our sites support early-phase and late-phase production, with integrated QC testing and global regulatory alignment.
Cell Therapy Technologies
Cell therapy developers face persistent challenges, from long vein-to-vein times and variable costs to manufacturing deviations, inconsistent yields and complex regulatory requirements.
Minaris Cell Therapies addresses these barriers with advanced technology platforms, including automated closed systems, optimized expansion processes and scalable bioreactor solutions, designed to enable more consistent, cost-efficient and GMP-ready manufacturing.
I’m developing…
Gene Edited Autologous Cell Therapies
Partnering with us enables you to accelerate your gene-edited autologous programs, including CAR-T and TCR-T programs, through proven process development, GMP manufacturing, and in-house testing, reducing vein-to-vein time and improving patient access.
Gene Edited
Allogeneic Cell Therapies
Our global network supports scalable, off-the-shelf therapies including NK, HSC, and iPSC platforms. We support client-defined allogeneic processes with integrated analytics and regulatory expertise.
Non – Edited
Allogeneic Cell Therapies
We provide end-to-end support for non-edited allogeneic therapies, combining robust platforms, global GMP facilities, and QC testing to enable reliable cell supply.
Non – Edited Autologous
Cell Therapies
With more than 25 years of autologous expertise, Minaris Advanced Therapies ensures consistency, scalability, and faster turnaround for patient-specific therapies, from early-phase to commercial supply.
Explore All
Minaris
Services
intro-section does not exist
Contact Us
Minaris Cell Therapies is dedicated to helping innovators advance complex cell therapy programs with confidence. Whether you are in early stage development or preparing for commercial launch, our process development expertise, cGMP manufacturing capabilities, global reach, and commitment to quality make us a trusted partner for scalable cell therapy manufacturing from development through commercialization.
